NOVN Novan Inc

Novan Inc together with its subsidiaries is a North Carolina based clinical-stage drug development company. It is engaged in the development and commercialization of nitric oxide-based therapies in dermatology.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/21/2016
Outstanding shares:  18,815,892
Average volume:  337,578
Market cap:   $93,514,983
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    66988N205
ISIN:        US66988N2053
Valuation   (See tab for details)
PE ratio:   -3.11
PB ratio:   3.33
PS ratio:   27.73
Return on equity:   -107.29%
Net income %:   -833.16%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy